No Antibiotic Prophylaxis Recommended

For a patient with choledocholithiasis and cholelithiasis without acute cholecystitis, who is afebrile with no leukocytosis, antibiotic prophylaxis is NOT indicated unless they are undergoing biliary tract surgery.

Clinical Context and Risk Stratification

Your patient presents with:

Choledocholithiasis (common bile duct stones)
Cholelithiasis (gallbladder stones)
No acute cholecystitis
No fever
No leukocytosis

This clinical picture represents uncomplicated biliary disease without infection. The absence of fever and leukocytosis indicates no active infectious process requiring treatment.

Guideline-Based Recommendations

For Non-Surgical Management

No antibiotics are indicated. The bile is not infected in this scenario, and antibiotics serve no prophylactic purpose outside of the perioperative setting 1.

For Surgical Management (If Planned)

The 2019 French guidelines on surgical antibiotic prophylaxis provide clear direction 2:

Laparoscopic Cholecystectomy WITHOUT Risk Factors:

No antibiotic prophylaxis required 2

Risk factors that would change this recommendation include:

Recent acute cholecystitis
Conversion to open laparotomy
Pregnancy
Immunosuppression
Intraoperative bile duct exploration

Biliary Tract Surgery (including procedures involving the common bile duct):

If surgical intervention for choledocholithiasis is planned, prophylaxis is recommended 2:

First-line options:

Cefazolin 2g IV (single dose; reinject 1g if duration >4 hours)
Cefuroxime 1.5g IV (single dose; reinject 0.75g if duration >2 hours)
Cefamandole 1.5g IV (single dose; reinject 0.75g if duration >2 hours)

For penicillin allergy:

Gentamicin 5mg/kg/day + Clindamycin 900mg IV (single dose; reinject clindamycin 600mg if duration >4 hours)

Supporting Evidence

Research confirms this approach:

A 2023 randomized trial demonstrated that ASA I patients (low anesthetic risk) without complications had only 9.1% bacteriobilia, supporting the avoidance of routine prophylaxis in low-risk elective cases 3
A 2022 study found that antibiotic administration in elective patients without acute cholecystitis is not justified 4
A 1997 prospective study concluded that elective biliary surgery for cholelithiasis without infectious risk factors is clean surgery and does not require systematic antibiotic prophylaxis 1

Critical Pitfalls to Avoid

Do not confuse choledocholithiasis with cholangitis: Your patient lacks fever and leukocytosis, ruling out acute cholangitis which would require immediate antibiotics
Do not give prophylaxis for diagnostic procedures: If MRCP or ERCP (without intervention) is planned for diagnosis only, no antibiotics are needed
Single dose only for surgery: If prophylaxis is given perioperatively, it should be a single dose (with redosing only if surgery is prolonged). Extended postoperative courses are not prophylaxis—they represent treatment and are not indicated 2
Timing matters: Prophylactic antibiotics should be given during anesthetic induction, not hours before or after surgery

Algorithm for Decision-Making

Patient with choledocholithiasis + cholelithiasis, no fever, no leukocytosis
│
├─ No surgery planned → NO ANTIBIOTICS
│
└─ Surgery planned
   │
   ├─ Simple laparoscopic cholecystectomy only
   │  └─ No risk factors* → NO ANTIBIOTICS
   │  └─ Risk factors present → Cefazolin 2g IV single dose
   │
   └─ Biliary tract surgery (CBD exploration, ERCP with intervention)
      └─ Cefazolin 2g IV single dose (or alternatives per guideline)

*Risk factors: acute cholecystitis, age >70, diabetes, immunosuppression, jaundice, emergency surgery

What is the recommended antibiotic prophylaxis guideline for a patient with choledocholithiasis and cholelithiasis without acute cholecystitis, who is afebrile and has no leukocytosis?

Have a follow-up question?